Q-Switched Nd:YAG Laser - Surgical frequency-doubled Nd:YAG laser system
Australia TGA ARTG Registered Device · Emergo Asia Pacific Pty Ltd T/a Emergo Australia · AMI Inc · Class IIb · Started July 13, 2023
Good Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia - Q-Switched Nd:YAG Laser - Surgical frequency-doubled Nd:YAG laser system
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- July 13, 2023
- Effective Date
- July 13, 2023
- Name
- AMI Inc
- Country
- South Korea
- Address
- RM 1412 SJ Techno Ville 278 Beotkkot-ro Geumcheon-gu, Seoul
The Nd:YAG surgical Laser is used in an operating room for the following purpose: Treatment of a pigmented lesions caused by cell or blood vessel rupture, Melasma, Ota’s nevus, Xanthelasma palpebrarum, DUH (Dyschromatosis Universalis Hereditaria), Red nevus, Partial Unilateral Lentiginosis (PUL) Cafe au lait, Becker’s nevus, etc.
Access comprehensive regulatory information for Q-Switched Nd:YAG Laser - Surgical frequency-doubled Nd:YAG laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by AMI Inc in South Korea. The device registration started on July 13, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.